Barney, owned by Allavena, was given an early version of the vaccine when diagnosed with an aggressive bone cancer and 10 months later is alive and well.
Barney, owned by Allavena, was given an early version of the vaccine when diagnosed with an aggressive bone cancer and 10 months later is alive and well. University of Queensland veterinary researchers are recruiting pet dogs diagnosed with cancer to test an experimental vaccine. The clinical research trial is for dogs recently diagnosed with canine appendicular osteosarcoma, a common bone tumour that affects 10,000 dogs a year globally. Dr Abhilasha Dadhich from UQ's School of Veterinary Science said researchers will assess two vaccine formulations. "These treatments aim to stimulate a dog's immune system to fight the spread of cancerous cells to other tissues of the body," Dr Dadhich said. "We're essentially 'waking up' the dog's immune system to fight the cancer. "This has real potential to enhance the life expectancy of the pets in the trial." To be eligible, dogs need to have been diagnosed with appendicular osteosarcoma of long bones of the limbs with no evidence of metastasis, or cancer spread, based on a physical exam and radiographs.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
